Tetralogic Pharmaceu (TLOG) 0.22 $TLOG 4 Trending Small

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tetralogic Pharmaceu (TLOG) 0.22 $TLOG

4 Trending Small Cap Stocks That You Need To Watch Today
ACCESSWIRE - Tue Apr 26, 7:27AM CDT
NEW YORK, NY / ACCESSWIRE / April 26, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. LPTN, TLOG, HTM and VSTM are on high volume watch. Continue reading to find out why these stocks are getting so much interest today. - If you want reports on the day's hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.
VSTM: 1.34 (-0.01), HTM: 0.72 (unch), LPTN: 2.37 (+0.02), TLOG: 0.22 (unch)

Penny Stocks To Watch: Four Top Small Cap Stocks on Monday April 25
ACCESSWIRE - Mon Apr 25, 11:44AM CDT
MIAMI, FL / ACCESSWIRE / April 25, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. TLOG, LPTN, OREX, and BTUUQ have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, Nasdaq and NYSE subscribe to our newsletter at DailyStockReporter.com.
OREX: 3.92 (-0.01), LPTN: 2.37 (+0.02), TLOG: 0.22 (unch)

James E. Goldschmidt, Ph.D. Joins CASI Pharmaceuticals As Vice President Of Business Development
PR Newswire - Mon Apr 18, 6:00AM CDT
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, welcomes James E. Goldschmidt, Ph.D. to lead its business development team. Dr. Goldschmidt is responsible for developing new partnerships and brings to the Company more than 25 years of biotechnology and pharmaceutical experience, including most recently at Macrophage Therapeutics, and prior thereto at ImmuneXcite, TetraLogic Pharmaceuticals, Johnson & Johnson, Wyeth Pharmaceuticals, and SmithKline Beecham. Dr. Goldschmidt is a graduate of Villanova University and holds a master's degree from Drexel University and a Ph.D. from Temple University School of Medicine.
JNJ: 119.08 (-0.26), CASI: 1.22 (+0.05), TLOG: 0.22 (unch)

Top Penny Stocks: Four Small Cap Stocks You Should Be Watching On April 15th
ACCESSWIRE - Fri Apr 15, 11:09AM CDT
MIAMI, FL / ACCESSWIRE / April 15, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. EBIO, EXXI, TLOG, and RMHB have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, Nasdaq and NYSE subscribe to our newsletter at DailyStockReporter.com.
EXXI: 0.13 (-0.01), EBIO: 4.89 (+0.01), TLOG: 0.22 (unch)

These Biotech Companies are Helping Turn Around the Sector for Major Gains in 2016
ACCESSWIRE - Wed Feb 03, 12:50PM CST
LAS VEGAS, NV / ACCESSWIRE / February 3, 2016 / The most notable of the pack is Propanc Health Group Corporation (PPCH), which is an exciting, young company within the sector. Propanc, whose focus is the development of new and proprietary treatments for cancer patients suffering from pancreatic, ovarian and colorectal cancers, recently announced the Company received a further $525,000 tranche from an institutional investor in order to progress their lead product, PRP, towards human trials. PPCH has already grabbed the attention of more than a few investors thanks to the Company's substantial growth in 2015 and expected growth in 2016.
RPTP: 7.24 (-0.21), TTNP: 5.68 (+0.06), MNKD: 0.73 (-0.07), TLOG: 0.22 (unch)

Insider Alert: Here's Why These Small Caps Could Be Ready To Bounceâ?¦
ACCESSWIRE - Wed Jan 13, 8:45AM CST
NEW YORK, NY / ACCESSWIRE / January 13, 2016 / UltimateStockAlerts.com is a NASDAQ & NYSE Only Stock Alerts Service focused on day trading, swing trading and long-term investing. Our newsletter subscribers have witnessed upside in excess of 600% with realized gains of 296% in 2015 from 32 alerts. Receive free trade alerts via email or text message (SMS) on your phone by texting message ULTIMATE to number 555-888. Today we are taking a look at four companies which we believe could provide investors with significant volatility in the near term.
TLOG: 0.22 (unch)

TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs
GlobeNewswire - Wed Jan 06, 3:11PM CST
Birinapant Shows No Activity in Randomized Phase 2 MDS Study
TLOG: 0.22 (unch)

Global Cutaneous T-Cell Lymphoma Therapeutics Pipeline Review, H2 2015 - 21 Companies & 24 Drug Profiles
M2 - Thu Dec 03, 7:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/9fwsbh/cutaneous_tcell) has announced the addition of the "Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cutaneous T-Cell Lymphoma and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - 4SC AG - Affimed Therapeutics AG - Chipscreen Biosciences Ltd - Cornerstone Pharmaceuticals, Inc. - Cyclacel Pharmaceuticals, Inc. - Eisai Co., Ltd. - Galderma S.A. - Innate Pharma SA - Johnson & Johnson - Karyopharm Therapeutics, Inc. - Kyowa Hakko Kirin Co., Ltd. - MedImmune, LLC - Neumedicines Inc. - Novartis AG - OncoSec Medical Inc. - Onyx Pharmaceuticals, Inc. - Sanofi - Seattle Genetics, Inc. - Soligenix, Inc. - Taiwan Liposome Company, Ltd. - TetraLogic Pharmaceuticals Drug Profiles - A-dmDT390-bisFv - AFM-13 - alemtuzumab - AMP-224 - Angeloxin - bexarotene - brentuximab vedotin - carfilzomib - CIGB-128 - CPI-613 - CS-055 - DNA IL-12 - everolimus - IPH-4102 - mogamulizumab - NMIL-121 - quisinostat hydrochloride - resminostat - sapacitabine - selinexor - SGX-301 - SHP-141 - trifarotene - vinorelbine tartrate For more information visit http://www.researchandmarkets.com/research/9f...eous_tcell
TLOG: 0.22 (unch), JNJ: 119.08 (-0.26), CYCC: 5.71 (+0.04), SGEN: 44.90 (+0.35), ONCS: 1.71 (+0.02), KPTI: 11.10 (+1.15), NVS: 78.27 (-0.50)

TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 57th Annual American Society of Hematology Annual Meeting
GlobeNewswire - Mon Nov 09, 6:00AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that two abstracts discussing clinical data on birinapant will be presented at the 57 Annual American Society of Hematology meeting to be held in Orlando from December 5-8, 2015, one of which is to be an oral presentation.
TLOG: 0.22 (unch)

TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update
GlobeNewswire - Wed Nov 04, 3:02PM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced financial results for the third quarter ended September 30, 2015. These results are included in TetraLogic's Quarterly Report on Form 10-Q which has been filed with the Securities and Exchange Commission.
TLOG: 0.22 (unch)

TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata
GlobeNewswire - Mon Nov 02, 6:00AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has an open U.S. Investigational New Drug application in support of a Phase 2 clinical trial of suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE) in approximately forty patients with alopecia areata.
TLOG: 0.22 (unch)

Pharmaceutical Sector Due Diligence Report - Searching for Opportunities Among the Bruised Small Cap Market
ACCESSWIRE - Wed Oct 07, 7:14AM CDT
NEW YORK, NY / ACCESSWIRE / October 7, 2015 / We profile four development stage companies with exciting prospects for future growth. In the report, we describe the companies, their products and provide recommendations on which have the better prospects to realize their growth potential.
CTRV: 1.16 (+0.01), TROV: 4.96 (+0.05), TLOG: 0.22 (unch), KERX: 4.13 (+0.03)

TetraLogic Reports Second Quarter Financial Results and Provides Clinical Programs Update
GlobeNewswire - Wed Aug 05, 3:01PM CDT
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced financial results for the second quarter ended June 30, 2015. These results are included in TetraLogic's Quarterly Report on Form 10-Q which has been filed with the Securities and Exchange Commission.
TLOG: 0.22 (unch)

TetraLogic to Present at the Jefferies 2015 Hepatitis B Summit
GlobeNewswire - Wed Jul 29, 6:32AM CDT
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) today announced that the Company will present at the Jefferies 2015 Hepatitis B Summit on Thursday, August 6, 2015 at 1:45 p.m. Eastern Time at the Boston Harbor Hotel. J. Kevin Buchi, CEO, will provide an overview of the Company, the Hepatitis B program and its corporate activities.
TLOG: 0.22 (unch)

TetraLogic Provides Update on Hepatitis B Clinical Program
GlobeNewswire - Mon Jul 20, 3:02PM CDT
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) a clinical-stage biopharmaceutical company focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today provided an update on the status of its hepatitis B virus (HBV) clinical program.
TLOG: 0.22 (unch)

Updates on MDS Clinical Program - Free Research Report on TetraLogic Pharmaceuticals Corporation
PR Newswire - Wed Jul 15, 8:10AM CDT
ACI Association has initiated research coverage on TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG). Select highlights from the internally released reports are being made available to the general public (included below), with access to the entirety of the research available to new members.
TLOG: 0.22 (unch)

TetraLogic Announces Update on MDS Clinical Program
GlobeNewswire - Tue Jun 30, 3:01PM CDT
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced preliminary data from the ongoing Phase 2A study of birinapant in combination with azacitidine in first line higher risk myelodysplastic syndromes (MDS). The study is being conducted as a precursor to the ongoing randomized Phase 2B study.
TLOG: 0.22 (unch)

Tracking the Pulse of the Healthcare Sector: Complementary Research on Corbus, Vascular Biogenics, Alexza, TetraLogic and Cleveland BioLabs
PR Newswire - Mon May 18, 6:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CRBP: 4.20 (+0.11), CBLI: 1.99 (+0.03), VBLT: 4.06 (-0.05), TLOG: 0.22 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 37

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 64

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 106

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 63

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 85

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 23

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 160

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 49

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 348

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading

Top 5 Most Recently Viewed Articles

Cloudastructure's Innovative AI Prevents Crime with 98% Success

Updated Category News Views 134

Cloudastructure's Impressive AI-Driven Crime Prevention Cloudastructure, Inc. (Nasdaq: CSAI) has emerged as a frontrunner in AI surveillance and remote guarding, successfully achieving an impressive crime deterrence rate exceeding 98% within a short span. This significant accomplishment, highlighted during the early months of the year, underscores the platform's...

Continue Reading
Apollo Global Management's Growth Strategy and Investor Outlook

Updated Category News Views 576

Barclays kept its Overweight rating on Apollo Global Management (NYSE: APO) back in early 2024, setting a price target of $128. This came as traders braced for the highly anticipated 2024 Investor Day where Apollo was expected to reveal its medium and long-term strategic objectives. Key numbers like assets under management (AUM), fundraising capabilities, fee-related...

Continue Reading
Leadership Changes at BlackLine: A New Era Unfolds Ahead

Updated Category News Views 367

BlackLine's Leadership Transition: A Strategic Move BlackLine, Inc. (Nasdaq: BL), the leading platform driving digital finance transformation, has announced a pivotal leadership transition aimed at enhancing its operational framework and growth trajectory. Therese Tucker's Evolving Role In a move that reflects the company's commitment to its strategic objectives, Therese...

Continue Reading
Hargreave Hale AIM VCT PLC Updates on Share Transactions

Updated Category News Views 41

Hargreave Hale AIM VCT PLC Engages in Strategic Share Acquisition Hargreave Hale AIM VCT PLC is focused on boosting shareholder value by taking strategic actions in the market. Recently, the company made a noteworthy announcement regarding its shares. Details of the Share Acquisition On a significant date, Hargreave Hale AIM VCT PLC acquired 367,436 ordinary shares at a...

Continue Reading
Tanmiah's Commitment to Sustainability Shines at Halal Forum

Updated Category News Views 156

Tanmiah's Role at the Makkah Halal Forum Tanmiah Food Company (TADAWUL: 2281, "Tanmiah"), a frontrunner in halal protein, recently highlighted its dedication as a Platinum Sponsor at the Makkah Halal Forum. This event serves as a crucial platform for showcasing the best halal services and products, allowing Tanmiah to demonstrate its leadership and innovative edge in the...

Continue Reading